Anatara Lifesciences today announced that it has signed an exclusive evaluation and license option agreement with the leading global animal health company Zoetis Inc. for Detach™, Anatara’s non-antibiotic anti-infective product.
Key points:
· Anatara signs an exclusive evaluation and license option agreement with the global animal health company, Zoetis Inc. to explore the utility of Detach™ a non-antibiotic anti-infective product, for use in food production animals
· Detach™ has the potential to play a part as an alternative to traditional antibiotics to control infections in farm animals, as public health officials worldwide seek strategies to combat antimicrobial resistance
· Agreement grants Zoetis an exclusive option to license Detach™ for development and marketing worldwide with Anatara retaining rights to Australia and New Zealand
Please click here to read the ASX announcement.